This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
Virtus Investment's July AUM Inches Up Sequentially on Net Inflows
by Zacks Equity Research
VRTS's July AUM rose to $170.8B, lifted by ETF and institutional inflows despite U.S. retail fund outflows.
IVZNegative Net Change VRTSNegative Net Change VCTRNegative Net Change
finance
LATAM Airlines July 2025 Traffic Improves Year Over Year
by Zacks Equity Research
LTM flew nearly 8 million passengers in July 2025, with traffic up 10.4% year over year, along with a slight surge in load factor to 86.7%.
BAPositive Net Change RYAAYNegative Net Change LTMNegative Net Change VLRSNegative Net Change
airlines transportation
Enterprise Oil Leak Temporarily Disrupts Seaway Pipeline Flows
by Zacks Equity Research
EPD addresses a crude leak at its Houston terminal, briefly disrupting Seaway pipeline flows and nudging Gulf Coast crude prices higher.
EPDPositive Net Change AMPositive Net Change ENBPositive Net Change FTKPositive Net Change
energy oil-energy
SBH's E-Commerce Sales Hit 11% of Net Sales: Can it Keep Rising?
by Zacks Equity Research
Sally Beauty's e-commerce now drives 10.6% of net sales, powered by marketplaces, innovation and targeted promotions.
ELNegative Net Change ULTAPositive Net Change SBHNegative Net Change COTYNegative Net Change
retail
BAC, JPM & COF-Owned Zelle App Faces Lawsuit Over Security Lapse
by Zacks Equity Research
Bank of America, JPMorgan and Capital One's Zelle faces a New York lawsuit alleging $1B theft from weak fraud safeguards.
BACPositive Net Change JPMPositive Net Change COFPositive Net Change
finance
General Dynamics Wins $323M Deal to Support Submarine Program
by Zacks Equity Research
General Dynamics secures a $322.6M Navy contract for Electric Boat to provide critical submarine engineering and support services.
NOCPositive Net Change GDPositive Net Change BAESYNegative Net Change HIIPositive Net Change
aerospace
Petrobras Q2 Earnings Miss on Oil Price Drop, Production Grows
by Zacks Equity Research
PBR posts lower Q2 earnings on weaker oil prices despite higher production, while boosting dividends and investments.
CVXPositive Net Change PBRPositive Net Change APAPositive Net Change MUSANegative Net Change
earnings energy oil-energy
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
by Zacks Equity Research
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
RMDPositive Net Change LIVNNegative Net Change INSPPositive Net Change NYXHPositive Net Change
medical medical-devices
Cardinal Health to Acquire Solaris Health for Urology Expansion
by Zacks Equity Research
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.
UNHNegative Net Change DVAPositive Net Change CAHPositive Net Change MCKPositive Net Change
medical medical-devices
Can Eylea HD and Dupixent Profits Revive Regeneron Stock?
by Zacks Equity Research
REGN banks on Dupixent and Eylea HD gains to offset Eylea's decline while oncology wins strengthen its diversified pipeline.
REGNPositive Net Change SNYPositive Net Change RHHBYPositive Net Change BAYRYNegative Net Change
biotechnology biotechs medical pharmaceuticals
NICE Grows Through Expanding Portfolio and Strong Partnerships
by Zacks Equity Research
NICE rides cloud growth, AI-driven CXone adoption, and deepened Salesforce ties to boost revenue and expand customer reach.
CRMPositive Net Change NICENegative Net Change RNGNegative Net Change SNOWPositive Net Change
artificial-intelligence tech-stocks
Will AI-Driven Fiber Boom Boost MasTec's Communications Business?
by Shrabana Mukherjee
MTZ posts record Q2 results as AI-fueled fiber demand propels 42% growth in its Communications segment and a $5B backlog.
PWRNegative Net Change DYNegative Net Change MTZNegative Net Change UNITNegative Net Change
artificial-intelligence construction
PPG Gains on Cost Actions and Acquisitions Amid Demand Softness
by Zacks Equity Research
PPG rides cost cuts, acquisitions and price hikes to offset weak demand in Europe and industrial coatings softness.
APDPositive Net Change PPGNegative Net Change DOWPositive Net Change EMNNegative Net Change
basic-materials
Can AvalonBay's Portfolio Strength Offset Development Setbacks?
by Zacks Equity Research
AVB's prime-market portfolio and strong balance sheet support growth, but supply pressures and delayed development occupancies pose challenges.
AVBNegative Net Change EQRPositive Net Change ESSNegative Net Change
finance reit
Here's Why You Should Retain Welltower Stock in Your Portfolio Now
by Zacks Equity Research
WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a concern.
VTRPositive Net Change DOCNo Net Change WELLPositive Net Change
finance reit
Unum to Benefit From Growing Premium Amid Rising Expenses
by Zacks Equity Research
Unum Group sees Q2 premium gains, but rising costs, margin pressure, and weak ROE temper its performance.
AFLPositive Net Change UNMPositive Net Change AMSFPositive Net Change GLPositive Net Change
finance insurance
HOOD's July 2025 DARTs Jump: Is Product Suite Expansion Paying Off?
by Zacks Equity Research
Robinhood's July DARTs surge across equities, options and crypto, as rapid product launches draw more active traders to its platform.
IBKRPositive Net Change TWPositive Net Change HOODNegative Net Change
cryptocurrency fin-tech finance
Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data
by Zacks Equity Research
TRIB's needle-free CGM+ sensor shows accurate 15-day results with no calibration, slashing costs and boosting access.
ABTPositive Net Change MDTPositive Net Change DXCMPositive Net Change TRIBPositive Net Change
medical medical-devices
AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs
by Zacks Equity Research
AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway.
AZNPositive Net Change BMYNegative Net Change PFEPositive Net Change MRKNegative Net Change
pharmaceuticals
SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease
by Zacks Equity Research
Sanofi wins EMA's orphan drug status for rilzabrutinib to treat IgG4-RD, a chronic, immune-mediated rare disease.
SNYPositive Net Change AMGNPositive Net Change RIGLPositive Net Change
pharmaceuticals
Copa Holdings' July 2025 Traffic Improves Year Over Year
by Zacks Equity Research
CPA posts strong July 2025 traffic, with rising load factor as demand growth outpaces capacity expansion.
RYAAYNegative Net Change CPANegative Net Change VLRSNegative Net Change
airlines
Automation Boom Fuels PATH's Performance in Growing RPA Market
by Zacks Equity Research
UiPath's alliances with tech giants, rising revenues, and strong customer retention fuel its edge in the fast-growing automation market.
AMZNNegative Net Change MSFTNegative Net Change CRMPositive Net Change PATHNegative Net Change
computers internet tech-stocks
3 Midstream Stocks That Can Sail Through Energy Volatility
by Nilanjan Banerjee
Kinder Morgan, MPLX and Williams boast fee-based midstream models built to withstand oil and gas price swings.
WMBPositive Net Change KMIPositive Net Change MPLXPositive Net Change
oil-energy
Celsius' Innovation Strategy: A Catalyst for Future Growth?
by Zacks Equity Research
CELH builds on its sugar-free edge with bold innovations, fresh flavors and high-impact marketing to fuel growth.
KOPositive Net Change PEPNegative Net Change MNSTPositive Net Change CELHPositive Net Change
consumer-staples
Rivian's Q2 Earnings Miss Expectations, Revenues Rise Y/Y
by Zacks Equity Research
RIVN's Q2 loss misses forecasts despite revenue gains from booming software and services, as the 2025 EBITDA loss outlook widens.
LEANegative Net Change GPINegative Net Change MBLYNegative Net Change RIVNNegative Net Change
auto-tires-trucks